Related Experiment Video
Updated: Dec 31, 2025
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
9.0K
Innovation in Oncology Drug Development
1Department of Medicine, Georgetown University Medical Center, 4000 Reservoir Rd. NW, Washington, DC 20007, USA.
Journal of Oncology
|January 9, 2020
Summary
Researchers have advanced the understanding of molecular drivers of cancer, leading to targeted therapies and innovative treatment regimens. Regulatory innovation supports the integration of precision medicine approaches for selected patient groups.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Understanding molecular lesions driving tumor growth, apoptosis evasion, and immune evasion is crucial.
- Tumor cells exhibit uncontrolled proliferation, resistance to programmed cell death, and metastasis.
- Immune system evasion by cancer cells presents a significant therapeutic challenge.
Purpose of the Study:
- To summarize progress in understanding cancer's molecular basis.
- To highlight the development of targeted therapies and innovative treatment regimens.
- To discuss the role of regulatory innovation in advancing precision medicine.
Main Methods:
- Review of molecular mechanisms of cancer.
- Analysis of targeted therapy development.
- Examination of regulatory adaptations for precision medicine.
Main Results:
- Significant advancements in identifying molecular lesions responsible for cancer.
- Development of targeted therapies and novel treatment strategies.
- FDA's embrace of regulatory innovation to support precision medicine.
Conclusions:
- Enhanced understanding of cancer biology has spurred targeted therapeutic development.
- Precision medicine approaches are being implemented for specific patient subpopulations.
- Regulatory innovation is key to facilitating the adoption of precision medicine in cancer care.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.5K
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.7K
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:26Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K